Revealing the Glioma Cancer Stem Cell Interactome, One Niche at a Time

Overview

Journal J Pathol

Specialty Pathology

Date 2017 Dec 29

PMID 29282720

Citations 15

Authors

Daniel J Silver

Justin D Lathia

Affiliations

Soon will be listed here.

Abstract

Glioblastoma (GBM) cancer stem cells (CSCs) are insidious. They extensively infiltrate brain tissue, resist radiotherapy and chemotherapy, and are thought to represent the ultimate drivers of disease progression. New research has identified CD109, a GPI-anchored protein, on a population of perivascular CSCs. Investigation of primary human tumour tissue suggests a role for CD109-expressing CSCs in the progression from low-grade to high-grade glioma, and animal modelling reveals a critical role for CD109 in the maintenance of the GBM CSC phenotype. Furthermore, CD109-expressing CSCs appear to drive the proliferation of adjacent non-stem tumour cells (NSTCs) in a rare example of CSC-NSTC cooperative interaction. With this Commentary, we highlight the newly revealed biology of CD109, and offer a synthesis of the published information on glioma CSCs in a variety of anatomical growth zones. We also discuss the landscape of interacting cells within GBM tumours, emphasizing the few reported examples of pro-tumourigenic, interactive tumour cell partnerships, as well as a variety of tumour cell-non-transformed neural cell interactions. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Citing Articles

Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity.

Auzmendi-Iriarte J, Otaegi-Ugartemendia M, Carrasco-Garcia E, Azkargorta M, Diaz A, Saenz-Antonanzas A Cancer Res. 2022; 82(7):1283-1297.

PMID: 35131870 PMC: 9359743. DOI: 10.1158/0008-5472.CAN-21-2161.

Voxelwise Prediction of Recurrent High-Grade Glioma via Proximity Estimation-Coupled Multidimensional Support Vector Machine.

Lao Y, Ruan D, Vassantachart A, Fan Z, Ye J, Chang E Int J Radiat Oncol Biol Phys. 2021; 112(5):1279-1287.

PMID: 34963559 PMC: 8923952. DOI: 10.1016/j.ijrobp.2021.12.153.

Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment.

Abballe L, Miele E World J Stem Cells. 2021; 13(7):670-684.

PMID: 34367473 PMC: 8316861. DOI: 10.4252/wjsc.v13.i7.670.

Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma.

Silver D, Roversi G, Bithi N, Wang S, Troike K, Neumann C J Clin Invest. 2021; .

PMID: 34255747 PMC: 8409594. DOI: 10.1172/JCI138276.

Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells.

Stanzani E, Pedrosa L, Bourmeau G, Anezo O, Noguera-Castells A, Esteve-Codina A Cancers (Basel). 2021; 13(12).

PMID: 34205341 PMC: 8235627. DOI: 10.3390/cancers13123055.

References

Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister S . Glioma. Nat Rev Dis Primers. 2016; 1:15017. DOI: 10.1038/nrdp.2015.17. View

Otvos B, Silver D, Mulkearns-Hubert E, Alvarado A, Turaga S, Sorensen M . Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. Stem Cells. 2016; 34(8):2026-39. PMC: 5820763. DOI: 10.1002/stem.2393. View

Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J . Brain tumour cells interconnect to a functional and resistant network. Nature. 2015; 528(7580):93-8. DOI: 10.1038/nature16071. View

Johansson E, Grassi E, Pantazopoulou V, Tong B, Lindgren D, Berg T . CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. Cell Rep. 2017; 20(7):1641-1653. DOI: 10.1016/j.celrep.2017.07.049. View

Kitano H . Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer. 2004; 4(3):227-35. DOI: 10.1038/nrc1300. View

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View

DeAngelis L . Brain tumors. N Engl J Med. 2001; 344(2):114-23. DOI: 10.1056/NEJM200101113440207. View

Lathia J, Gallagher J, Heddleston J, Wang J, Eyler C, MacSwords J . Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell. 2010; 6(5):421-32. PMC: 2884275. DOI: 10.1016/j.stem.2010.02.018. View

Shiraki Y, Mii S, Enomoto A, Momota H, Han Y, Kato T . Significance of perivascular tumour cells defined by CD109 expression in progression of glioma. J Pathol. 2017; 243(4):468-480. DOI: 10.1002/path.4981. View

10.

Silver D, Siebzehnrubl F, Schildts M, Yachnis A, Smith G, A Smith A . Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J Neurosci. 2013; 33(39):15603-17. PMC: 3782629. DOI: 10.1523/JNEUROSCI.3004-12.2013. View

11.

Scherer H . A CRITICAL REVIEW: THE PATHOLOGY OF CEREBRAL GLIOMAS. J Neurol Psychiatry. 2011; 3(2):147-77. PMC: 1088179. DOI: 10.1136/jnnp.3.2.147. View

12.

Edwards L, Woolard K, Son M, Li A, Lee J, Ene C . Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst. 2011; 103(15):1162-78. PMC: 3149042. DOI: 10.1093/jnci/djr224. View

13.

Amberger V, HENSEL T, Ogata N, Schwab M . Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998; 58(1):149-58. View

14.

Holland E . Glioblastoma multiforme: the terminator. Proc Natl Acad Sci U S A. 2000; 97(12):6242-4. PMC: 33993. DOI: 10.1073/pnas.97.12.6242. View

15.

Lee S, Frattini V, Bansal M, Castano A, Sherman D, Hutchinson K . An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016; 529(7585):172-7. PMC: 5384647. DOI: 10.1038/nature16475. View

16.

Lathia J, Mack S, Mulkearns-Hubert E, Valentim C, Rich J . Cancer stem cells in glioblastoma. Genes Dev. 2015; 29(12):1203-17. PMC: 4495393. DOI: 10.1101/gad.261982.115. View

17.

Reinartz R, Wang S, Kebir S, Silver D, Wieland A, Zheng T . Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma. Clin Cancer Res. 2016; 23(2):562-574. PMC: 5241221. DOI: 10.1158/1078-0432.CCR-15-2089. View

18.

Wang H, Lathia J, Wu Q, Wang J, Li Z, Heddleston J . Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells. 2009; 27(10):2393-404. PMC: 2825688. DOI: 10.1002/stem.188. View

19.

Glas M, Rath B, Simon M, Reinartz R, Schramme A, Trageser D . Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol. 2010; 68(2):264-9. PMC: 4445859. DOI: 10.1002/ana.22036. View

20.

Markovic D, Vinnakota K, Chirasani S, Synowitz M, Raguet H, Stock K . Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci U S A. 2009; 106(30):12530-5. PMC: 2718387. DOI: 10.1073/pnas.0804273106. View